摘要
肝癌中医归属于"肝积"范畴,郑洪新教授认为,肝积的中医治疗主要以术后、手术未能尽除或晚期患者为主,随着病情演变,此类患者的病机发生变化,与初病时大有不同,病位多涉及肝胆脾胃,或肝肾同病,以正气不足为主,兼有气滞血瘀、湿热之毒内盛,患者多有情志抑郁、疏泄不畅,每每加重病情。因此提出治疗四法:调气为上,扶正祛邪,辨证论治,少用毒药。多数患者经郑师治疗后,症状均明显好转,精神压力明显减轻,生活质量得到提升。典型病例患者已存活5.4年。
Liver cancer belongs to the category of"hepatic effusion"in traditional Chinese medicine.Professor ZHENG Hongxin believes that the traditional Chinese medicine treatment of hepatic effusion is mainly based on postoperative and failed surgery or advanced patients.As the disease evolves,the pathogenesis of such patients changes,which is very different from that at the beginning of the disease.Involving liver,gallbladder,spleen and stomach,or liver and kidney disease,mainly due to deficiency of righteousness,Qi stagnation,blood stasis,dampness and heat poisoning,patients often have emotional depression,poor drainage,and often aggravate the disease.Therefore,the four methods of governing the law are put forward:regulating the Qi as the uppermost,relieving the evil,resolving the symptoms,and using less poison.Most of the patients were significantly improved after ZHENG’s treatment,the mental stress was significantly reduced,and the quality of life was improved.Patients in typical cases have survived for 5.4 years.
作者
杨硕
郑洪新
YANG Shuo;ZHENG Hongxin(The Fourth Affiliated Hospital of Liaoning University of Traditional Chinese Medicine,Shenyang 110101,Liaoning,China)
出处
《辽宁中医药大学学报》
CAS
2020年第3期189-192,共4页
Journal of Liaoning University of Traditional Chinese Medicine
基金
第六批全国老中医药专家学术经验继承工作项目[国中医药人教发(2017)29号]。
关键词
肝癌
中医药
临床经验
治法
liver cancer
traditional Chinese medicine
clinical experience
treatment